Sodium Valproate

Specifications

1069-66-5CAS Number

213-961-8EC Number

sodium 2-propylpentanoateIUPAC Name

C8H15NaO2Chemical Formula

166.19 g/molMolecular Weight

Sodium valproate; Sodium 2-propylpentanoate; 1069-66-5; Valproate sodium; Valproic acid sodium salt; Sodium 2-propylvalerate; Orfiril; DEPACON; Valproic Acid, Sodium Salt; Selenica; 2-Propylvaleric acid sodium salt; 2-Propylpentanoic acid sodium salt; Valproic acid sodium salt (1:1); Abbott 44090; DTXSID5037072; Natrii valproas; 5VOM6GYJ0D; ABBOTT-44090; KW-6066N; NSC-732626; NSC-757376; CHEBI:9925; DTXCID3017072; A-44090; Episenta; Kentilim; Orlept; Epilim iv; Epilim chronosphere; Epilim chrono 200; Epilim chrono 300; Epilim chrono 500; Epilim 200; Epilim 500; RefChem:56201; Monosodium 2-propylpentanoate; 213-961-8; Valproic acid sodium; Pentanoic acid, 2-propyl-, sodium salt; Valerin; MFCD00078604; Valproate Sodium [USAN]; Valproic acid sodium salt (Sodium valproate); Valproic Acid (sodium salt); Valproic acid, sodium; sodium;2-propylpentanoate; Eurekene; Labazene; Depakene (TN); Natrium valproat; Valproate sodium (USAN); Pentanoic acid, 2-propyl-, sodium salt (1:1); Dipropylacetate sodium; Sodium dipropylacetate; Sodium bispropylacetate; CHEMBL433; Valproinsaeure, natrium; Sodium n-dipropylacetate; SMR000875243; Sodium 2-n-propyl-pentanoate; KW 6066N; EINECS 213-961-8; UNII-5VOM6GYJ0D; Valeric acid, 2-propyl-, sodium salt; 2-propylpentanoic acid sodium; Valproate sodium [USAN:USP]; Valproicacidsodium; Selenica (TN); Valproate sodium salt; Sodium valproate CRS; Valproic acid (sodium); Lopac-P-4543; 2-Propylpentanoic acid Na; Sodium valproate (JP18); SCHEMBL35027; MLS001332431; MLS001332432; MLS002153189; SPECTRUM1500606; SODIUM VALPROATE [JAN]; orb1227042; orb1308057; VALPROATE SODIUM [VANDF]; HMS500N15; Valproic acid sodium salt, 98%; SODIUM VALPROATE [MART.]; SODIUM VALPROATE [WHO-IP]; VALPROATE SODIUM [WHO-DD]; GLXC-02565; HMS1921I21; HMS2092C12; HMS2230E16; HMS3262B20; HMS3369L11; HMS3648A12; HMS3654I14; HMS3872G13; HMS3884E05; HMS5079M11; HY-10585AR; Valproic acid (sodium) (Standard); MSK10491; Tox21_302623; Tox21_500889; CCG-40071; EBC-03420; HB0867; HY-10585A; s1168; AKOS005066057; VALPROATE SODIUM [ORANGE BOOK]; AC-8391; CCG-208088; CCG-266330; CS-1764; FS15501; LP00889; NATRII VALPROAS [WHO-IP LATIN]; NSC 732626; NSC 757376; SODIUM VALPROATE [EP MONOGRAPH]; VALPROATE SODIUM [USP IMPURITY]; NCGC00016192-01; NCGC00016192-02; NCGC00016192-03; NCGC00016192-04; NCGC00094208-01; NCGC00094208-02; NCGC00094208-03; NCGC00167849-01; NCGC00167849-02; NCGC00256651-01; NCGC00261574-01; AS-13150; SY058189; 2-Propylpentanoic acid sodium salt (1:1); CAS-1069-66-5; DB-059527; SODIUM 2-PROPYLPENTANOATE [WHO-IP]; EU-0100889; NS00079512; S0894; SW219169-2; D00710; H11308; P 4543; VALPROIC ACID SODIUM SALT (1:1) [MI]; EN300-7366609; F243113; Q4347890; Sodium valproate, British Pharmacopoeia (BP) Reference Standard; Sodium valproate, European Pharmacopoeia (EP) Reference StandardSynonyms